Retinal Insider

How to Interpret Clinical Trial Outcomes

Making sense of primary and secondary endpoint outcomes in macular degeneration and diabetic macular edema trials.

High-dose Anti-VEGF in Refractory Wet AMD

Researchers say that, for certain cases, increased doses of these drugs may yield better results than a standard regimen.

Retinal Prostheses¬≠— Now and in the Future

A discussion of the unique strategies used by the major retinal prostheses initiatives and their current results.

Machine Learning for Diabetic Retinopathy

Adding computers to the mix may help ophthalmologists around the world catch and treat DR more effectively.

OCT Technology: Will We Be “Swept” Away?

A look at the differences between spectral-domain and swept-source OCT, and the potential clinical benefits of swept-source.

Combo Therapy: When One Drug’s Not Enough

A look at researchers’ attempts to gang up on wet age-related macular degeneration.

A Review of Portable Retinal Imaging

A guide to using common devices such as smartphones as well as more exotic consumer-level cameras to capture images.

The Clinical Utility of OCT Angiography

Retina specialists experienced in OCTA discuss the strengths—and the limitations—of this promising new technology.

Ocular Vitamins: Who Benefits?

It may be possible to stretch the boundaries of the AREDS’ findings and still give patients positive results.

Avoiding the Traps of Hydroxychloroquine Use

Proper communication between specialties and using the correct formula for dosing can curb toxicity.